[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-AVBP":3,"stock-news-AVBP":31,"homepage-market-summary":73},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"AVBP","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"ArriVent BioPharma, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.","77","Newtown Square, PA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},28.27,29.26,29.33,27.8,28.93,-0.66,-2.28,507399.014546,7695,28.4465,35.83,17,487693.40520600794,59.9,674,{"ticker":4,"count":32,"articles":33},7,[34,40,46,52,58,63,68],{"title":35,"link":36,"pubDate":37,"description":38,"source":39},"(AVBP) Movement as an Input in Quant Signal Sets - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxQcGFxc3VVT082Q3pOcm5jbktDcTFnaHItQUlWdDlRNWpGeDc5VldFQTctUEZXTjF3QVQ4Tko0TWRBNmUzSk1VX0EyeDNQVnk0bUcwVG52ZEwxUHpDQ2JUNUNSRnRNRlpYVmg4TF9Td0F4akRYT256eGZHT1BPX0Y0a0hUWkRHMGJsZWs5T1hsV2o1Szl2TWhhbV94OUtwTElmdE1YZGZ1d2hZdXY4VHhkeG9TWlg0YUpPNmZGVU5mUGc5eTAx?oc=5","Fri, 25 Sep 2026 19:26:02 GMT","(AVBP) Movement as an Input in Quant Signal Sets Stock Traders Daily","Stock Traders Daily",{"title":41,"link":42,"pubDate":43,"description":44,"source":45},"Are Medical Stocks Lagging Avantor (AVTR) This Year? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxQWGx1WUh4alJGQ1B4enA0U0VlYmpFV3MzaTZFR0dweXdmUWtOQmcxNlI3WG1qYk9kZ1dRR3pjUEwwYk90R2YxMnNucHE3UmM3bmhmaUhtSV9NV1pjaWVOUGphZGQ0MHpUaTUyejE1dWhoUk5JaUhUVEJ5cE9pRWZ6Yml4TUhINXoxVXVvcnBrTkFSX3FqZjNZeTROaDRTUzlkZ2c?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","Are Medical Stocks Lagging Avantor (AVTR) This Year? Yahoo Finance","Yahoo Finance",{"title":47,"link":48,"pubDate":49,"description":50,"source":51},"Cantor Fitzgerald reiterates Overweight on ArriVent stock - in.investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxQY2lTdDBqdXlmc0NiVGEyZUcydXkyWFdOUkdXekU3bTBKTUF4ZXV1Y1V1TFgyT09MdllNNVpKMm9jWXhyd19mUXE4WUdBTWRPUWF2V1hVWjBtN0t6a19kcklKMTVwejJTdmQ4SlQ2YUd6MlkteWVmNnpIbUltQjBBNHotbHEtd01PaVFxWGJ2NmdwNkZyNjhHYlRDd3pweVdsZHQ4aHloT2ZWXzdEcjJ2NVdiQ2hNMmNmNWc?oc=5","Tue, 22 Sep 2026 12:45:13 GMT","Cantor Fitzgerald reiterates Overweight on ArriVent stock in.investing.com","in.investing.com",{"title":53,"link":54,"pubDate":55,"description":56,"source":57},"AVBP Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Earnings Expansion Phase - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxPdmhMNU9ycmh3d1JpeEt4Y2tYUXIxLURtdVVKRE9mUHUxQ0NLa1RZV3E3a3IxX1lqZlpZdm81dXFZeFRMSVZtM3V4a2RDU2NVS1dlUUtZblZWR1BUZVJ6TUtPaWZ3VlMwUk1hTVdwNXV5MXNRUDM2WDZXX3hqZmNfWm9XVkpRTnRqRVBrckRMWkNXSWpWbE9kU2NLZTNBdmIwaG91VmFRWExBWmJ6Nk9QNkJvWDRYZnExcGM5YUlPRF8?oc=5","Sun, 20 Sep 2026 17:30:12 GMT","AVBP Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Earnings Expansion Phase dars.gov.et","dars.gov.et",{"title":59,"link":60,"pubDate":61,"description":62,"source":57},"AVBP Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Revenue Breakdown Analysis - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7AFBVV95cUxOYnpnNENaWnNSX0Y3UHdLa0RlMDlMSmpHcEItMUhlN1VuT3BySXhnal9Ha0l3YlF3ZGNDWTl0N1kyYTJvclQ0a1BjYXE4MlNiYzFER3oxVEZhMHFSWDk5djFuZTR3WGlzVzcwbzYycmFwWExSZGlaSlZhWTFpajI2c3RMX3FWaUhxT01PWGFBTzg0QjVtYXhrOXNLTFV1d2FtUzVuM28wUmFOb1BIYnVTRG0wRmI4bjJRVDl0UjBrdFZfcjlHeFlQOER1allsTFYzT1ZDZDNVbjBPY1pPN0trWFFhQnlmczNLQ2FVRQ?oc=5","Sun, 20 Sep 2026 17:30:23 GMT","AVBP Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Revenue Breakdown Analysis dars.gov.et",{"title":64,"link":65,"pubDate":66,"description":67,"source":57},"AVBP Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Analyst Coverage Count - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6gFBVV95cUxOOUtHMjNQTFoyV2NnSXg3UWVDeE94YWtaMElNYzZ5NUFHVFI3RzdLMDhIOTRJTnNUWU80X0Zrbk5iWVRwSE50YlFQZVVTMUl1SnlqdHAycUY4ZHA1TG5paGwyU2pJX0ZhTENXczBtbW5ic0hJbVFWRVh1c3E0ci1SYVFNV1pSQ0ZrbENYTE5UTHRHeDFEeWN1cHQ3RHRrVlRyQmJIaURnYkxxcWFsOVVnRWpsdHFIeUlUUk1LM0pXQmNZZGNaZVhlczFLVUZ3ODVhTG9FbDdFVjBkUG1zbWFrbl93ZnZOdGxPVWc?oc=5","Sun, 20 Sep 2026 07:00:00 GMT","AVBP Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Analyst Coverage Count dars.gov.et",{"title":69,"link":70,"pubDate":71,"description":72,"source":57},"AVBP Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Profit Margin Analysis - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-gFBVV95cUxQd0l1eVlQOUN0TDZnNkx3S3ZrNkN6WlBWblNaZEQzRXdsdWE0QmRIMkZPLW4yd3NlUDZjU2hld2RWRi04aHBISGh6NHVNMHp3UkJVd2JtU3dMcWpIUFVFRFZjZHFrcWtHbWRfMTFVMkV1dnNvcHZCbjg5STRIZ3lXYlhxRmxCWGRxTHNrUFdkN0ltb213cW9UVmFjem51a3drdXJJRnd6ejJ2bzF2aDdEM2V1bGNOMjhKTG9SVnVLdjZidFBPYTN5ZWdGendPZnZJVmd2RHdqbkJYVWhzdUY4UGFoSW5PMlJoZ2xtaC1Ib1hWQURKRzRGN0dn?oc=5","Sun, 20 Sep 2026 17:41:48 GMT","AVBP Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Profit Margin Analysis dars.gov.et",{"status":74,"indices":75,"watchlist":119,"sectors":141,"benchmarks":197},"success",[76,84,91,98,105,112],{"symbol":77,"name":78,"price":79,"change":80,"pct_change":81,"is_up":82,"sparkline":83,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":82,"sparkline":90,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":82,"sparkline":97,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":99,"name":100,"price":101,"change":102,"pct_change":103,"is_up":82,"sparkline":104,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":106,"name":107,"price":108,"change":109,"pct_change":110,"is_up":82,"sparkline":111,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":113,"name":114,"price":115,"change":116,"pct_change":117,"is_up":14,"sparkline":118,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[120,127,134],{"symbol":121,"name":122,"price":123,"change":124,"pct_change":125,"is_up":82,"sparkline":126,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":128,"name":129,"price":130,"change":131,"pct_change":132,"is_up":82,"sparkline":133,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":135,"name":136,"price":137,"change":138,"pct_change":139,"is_up":82,"sparkline":140,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[142,147,152,157,162,167,172,177,182,187,192],{"name":143,"etf":144,"change":145,"price":146,"is_up":82},"Technology","XLK",1.01,199.81,{"name":148,"etf":149,"change":150,"price":151,"is_up":82},"Financials","XLF",0.06,53.49,{"name":153,"etf":154,"change":155,"price":156,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":158,"etf":159,"change":160,"price":161,"is_up":82},"Consumer Cycl","XLY",1.13,110.04,{"name":163,"etf":164,"change":165,"price":166,"is_up":82},"Consumer Staples","XLP",0.25,80.53,{"name":168,"etf":169,"change":170,"price":171,"is_up":82},"Energy","XLE",0.4,62.95,{"name":173,"etf":174,"change":175,"price":176,"is_up":82},"Industrials","XLI",0.78,169.95,{"name":178,"etf":179,"change":180,"price":181,"is_up":82},"Materials","XLB",0.66,48.86,{"name":183,"etf":184,"change":185,"price":186,"is_up":82},"Real Estate","XLRE",0.32,40.81,{"name":188,"etf":189,"change":190,"price":191,"is_up":82},"Utilities","XLU",0.38,39.83,{"name":193,"etf":194,"change":195,"price":196,"is_up":82},"Comm Services","XLC",0.35,110.32,[198,203,207,211],{"ticker":199,"name":200,"price":201,"change":202,"is_up":82},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":204,"name":205,"price":206,"change":132,"is_up":82},"QQQ","Invesco QQQ Trust",749.58,{"ticker":208,"name":209,"price":210,"change":96,"is_up":82},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":212,"name":213,"price":214,"change":110,"is_up":82},"IWM","iShares Russell 2000",281.52]